Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
about
Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleedingPrevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxisWSES guidelines for management of Clostridium difficile infection in surgical patientsAcid suppression and the risk of Clostridium difficile infectionCurrent Trends in the Epidemiology and Outcomes of Clostridium difficile InfectionA Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management.Probiotics in Human Immunodeficiency Virus Infection: A Systematic Review and Evidence Synthesis of Benefits and Risks25 Years of Proton Pump Inhibitors: A Comprehensive Review.Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control studyProton pump inhibitors alter the composition of the gut microbiotaDrug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.Cumulative and temporal associations between antimicrobial prescribing and community-associated Clostridium difficile infection: population-based case-control study using administrative data.Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.Predictors of rehospitalization among elderly patients admitted to a rehabilitation hospital: the role of polypharmacy, functional status, and length of stay.Epidemiology of Clostridium difficile infectionImpact of Clostridium difficile infection on inflammatory bowel disease outcome: a review.Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in JapanAcid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias.Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.Proton pump inhibitors: Risks of long-term use.Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.The impact of proton pump inhibitors on the human gastrointestinal microbiomeAdvances in the evaluation and management of esophageal disease of systemic sclerosis.Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.Clostridium difficile infection in the community: are proton pump inhibitors to blame?Clostridium difficile: improving the prevention paradigm in healthcare settings.Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy.A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based StudyAdverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback.The Indications, Applications, and Risks of Proton Pump InhibitorsAdverse drug reactions in special populations - the elderly.
P2860
Q24201985-7F01A928-107F-461E-81CD-6F9FD0A55D7AQ26768234-F868B742-F4E1-4C8F-AB06-5EB298C199F1Q26795429-AB2D0735-37A6-4124-9079-EE167B6520A7Q26823599-1B3BB5CD-B924-4F63-BA8F-5FE6362C13EFQ26996462-CACE64E2-E840-4C09-A8B9-E2520E2FECEAQ27335693-E4D9B15E-8EC5-4215-90C0-39758A3FC623Q28069649-619ECADE-F0F9-4324-9E00-8863706C266CQ28070003-17B9D28D-5D64-46F9-95D5-3CA04DFF94C9Q28543390-E472E9BB-4C71-4FE8-AFEF-C0DF7678E6A6Q28603378-0EBD421E-C9F9-4BFF-B41D-563BDE77D651Q28607457-153A0407-50F9-47AC-BCFE-FB2B90B81210Q30412203-F631B430-A803-4EF9-AA0D-362320EB9703Q30457290-EAFA647E-5294-4471-B8CF-0BDD20B0039BQ30619561-502768F5-4CCD-45BE-A69E-A6DDE0DDBE7CQ31150338-92D9F276-EA59-42F0-9AA8-084106BD1964Q33729925-4CFF394D-CBB0-40E1-A175-E16F1BB3122FQ33767958-03747DAF-8FC3-4914-9D00-EA296286E692Q33910972-9A175059-3247-40D5-A4E2-5D0C126FCEB6Q34027474-6CC66124-6E76-43B1-AB77-448C616A3955Q34137328-4A36E953-05E5-4382-907D-8ACAB2FF1FB5Q34151774-CDEF0A8A-395F-4A22-A8CB-F26A5DBA88AAQ34314206-BACDCCE2-66CB-4F98-B9D0-BDD91A89A503Q34331595-769D5DE7-004E-4F0B-AE95-E565960542ACQ34400622-F1CB2A44-F0DD-4E51-AE47-1913E08F3083Q34404967-ED767637-3CC5-4431-8AE8-2FBF78A37369Q34510524-377B17A1-F81E-4FAE-B25D-3AE1E92EE2A5Q34549406-2FA06469-BB76-4D42-8DEC-FF66664E87CDQ34566765-A230D099-3DFA-4E86-92F6-AF7736F43333Q34625008-1E23AC62-ED09-4527-AB1F-A6AC14FDC43FQ34666835-8D0D3DA2-D72D-4FCA-B22D-362CA7730A9AQ34951199-BC2D407F-0602-46DD-BF5A-105D2EB37998Q35031254-D16AA74D-F3E1-49E6-944E-B20ACD51BC6EQ35222472-B9F2FE2C-ADE2-4245-827F-BB0A9939B5E3Q35260563-272DD078-6F3B-4132-9464-972778981643Q35938718-77FAF086-979D-49AE-B3A1-0C8E6B88A2FFQ35999704-BC557FF9-924E-4941-8CC5-093191718509Q36020285-9741597A-D6AA-4769-AF2F-50E838359659Q36083653-0F397403-4912-4AFE-BC2D-4FDA0CF5DB21Q36091187-B481077E-CC4A-44E5-9A8F-FE1A156A4A4FQ36125513-908A04AD-45F3-44F0-A83D-52959A0FDCD4
P2860
Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk of Clostridium difficile ...... nd antibiotics: meta-analysis.
@en
type
label
Risk of Clostridium difficile ...... nd antibiotics: meta-analysis.
@en
prefLabel
Risk of Clostridium difficile ...... nd antibiotics: meta-analysis.
@en
P2093
P2860
P921
P356
P1476
Risk of Clostridium difficile ...... nd antibiotics: meta-analysis.
@en
P2093
Aaron Kobina Arthur
Chukwudubem Ifeanyichukwu Anibueze
Rodrigo Cavallazzi
Yoon Kong Loke
P2860
P2888
P304
P356
10.1038/AJG.2012.108
P407
P577
2012-04-24T00:00:00Z
P5875
P6179
1046477150